Skip to content

Effects of Intragastric Balloon on Bone, Metabolic and Respiratory Parameters

Effects of Intragastric Balloon on Bone, Metabolic and Respiratory Parameters

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01598233
Enrollment
50
Registered
2012-05-15
Start date
2011-03-31
Completion date
2012-08-31
Last updated
2014-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome, Obesity, Overweight

Brief summary

The purpose of this study is to evaluate the effects of intragastric balloon on bone, metabolic and respiratory parameters in 50 patients with metabolic syndrome.

Interventions

DEVICESilimed Intragastric balloon

Intragastric balloon inflated with 650 ml of NaCl 0.9% mixed with 20 ml of methylene blue solution

Sponsors

Universidade Federal do Rio de Janeiro
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* metabolic syndrome (IDF criteria)

Exclusion criteria

* menopause * older than 50 years * diabetes mellitus

Design outcomes

Primary

MeasureTime frameDescription
Change in bone mineral density and body compositionBaseline and 6 monthsBone mineral density and body composition by dual-energy X-ray absorptiometry (DXA)
Change in fasting and postprandial glucoseBaseline and 6 months
Change in Pulmonary function testsBaseline and 6 monthsPulmonary function tests consiste of spirometry, body plethysmograph, diffusing capacity for carbon monoxide (DLco), and respiratory muscle strength. Measurements are conducted using the Collins Plus Pulmonary Function Testing Systems (Warren E. Collins, Inc., Braintree, MA, USA).
Change in bone microarchitectureBaseline and 6 monthsBone microarchitecture by high-resolution peripheral quantitative computed tomography
Change in lipid profileBaseline and 6 monthsTotal cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026